EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

APOER2 splicing repertoire in Alzheimer’s disease: Insights from long-read RNA sequencing

Christina M Gallo iD, Sabrina A Kistler iD, Anna Natrakul iD, Adam T Labadorf iD, Uwe Beffert iD, Angela Ho iD

PLOS Genetics · 2024

DOI: 10.1371/journal.pgen.1011348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, 2024. Verfasst von Christina M Gallo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Boston University, Boston, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Alzheimer Disease, Reelin Protein, LDL-Receptor Related Proteins, Alternative Splicing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIGMS NIH HHS, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disrupted alternative splicing plays a determinative role in neurological diseases, either as a direct cause or as a driver in disease susceptibility. Transcriptomic profiling of aged human postmortem brain samples has uncovered hundreds of aberrant mRNA splicing events in Alzheimer’s disease (AD) brains, associating dysregulated RNA splicing with disease. We previously identified a complex array of alternative splicing combinations across apolipoprotein E receptor 2 ( APOER2 ), a transmembrane receptor that interacts with both the neuroprotective ligand Reelin and the AD-associated risk factor, APOE. Many of the human APOER2 isoforms, predominantly featuring cassette splicing events within functionally important domains, are critical for the receptor’s function and ligand interaction. However, a comprehensive repertoire and the functional implications of APOER2 isoforms under both physiological and AD conditions are not fully understood. Here, we present an in-depth analysis of the splicing landscape of human APOER2 isoforms in normal and AD states. Using single-molecule, long-read sequencing, we profiled the entire APOER2 transcript from the parietal cortex and hippocampus of Braak stage IV AD brain tissues along with age-matched controls and investigated several functional properties of APOER2 isoforms. Our findings reveal diverse patterns of cassette exon skipping for APOER2 isoforms, with some showing region-specific expression and others unique to AD-affected brains. Notably, exon 15 of APOER2 , which encodes the glycosylation domain, showed less inclusion in AD compared to control in the parietal cortex of females with an APOE ɛ3/ɛ3 genotype. Also, some of these APOER2 isoforms demonstrated changes in cell surface expression, APOE-mediated receptor processing, and synaptic number. These variations are likely critical in inducing synaptic alterations and may contribute to the neuronal dysfunction underlying AD pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseReelin ProteinLDL-Receptor Related ProteinsAlternative SplicingHumansProtein IsoformsSequence Analysis, RNAFemaleAgedBrainApolipoproteins EMaleHippocampusAged, 80 and overRNA SplicingNerve Tissue Proteins

Substanzen

low density lipoprotein receptor-related protein 8Reelin ProteinLDL-Receptor Related ProteinsRELN protein, humanProtein IsoformsApolipoproteins ENerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Biology, Boston University, Boston, Massachusetts, United States of America.
  • Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.
  • Bioinformatics Program, Boston University, Boston, Massachusetts, United States of America.
  • Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.

ORCID-Profile: Christina M Gallo, Sabrina A Kistler, Anna Natrakul, Adam T Labadorf, Uwe Beffert, Angela Ho

Förderung

  • NIA NIH HHS
  • NIGMS NIH HHS
  • National Institute of Health
  • National Institute of General Medical Sciences
  • Harold and Margaret Southerland Alzheimer's Research Fund

Zitieren

APA

Gallo, C. M., Kistler, S. A., Natrakul, A., Labadorf, A. T., Beffert, U., & Ho, A. (2024). APOER2 splicing repertoire in Alzheimer’s disease: Insights from long-read RNA sequencing. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011348

Vancouver

Gallo CM, Kistler SA, Natrakul A, Labadorf AT, Beffert U, Ho A. APOER2 splicing repertoire in Alzheimer’s disease: Insights from long-read RNA sequencing. PLOS Genetics. 2024. doi:10.1371/journal.pgen.1011348

BibTeX
@article{Gallo2024,
  author = {Gallo, Christina M and Kistler, Sabrina A and Natrakul, Anna and Labadorf, Adam T and Beffert, Uwe and Ho, Angela},
  title = {APOER2 splicing repertoire in Alzheimer’s disease: Insights from long-read RNA sequencing},
  journal = {PLOS Genetics},
  year = {2024},
  doi = {10.1371/journal.pgen.1011348}
}
Kostenlos starten →